Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
ENAH	"FLJ10773, MENA, NDPP1"	ENSG00000154380	"ENAH, actin regulator"	Q8N8S7	1	225486835-225653142	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 61.0"	"Low region specificity"	"Detected in all"							"HPA028448, HPA028696"	Enhanced		Enhanced	"Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA		18000	"Plasma membrane, Focal adhesion sites, Cytosol"		"HPA028448: AB_10600766, HPA028696: AB_10611249"	"unprognostic (2.56e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.35e-2)"	"unprognostic (5.61e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.21e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.22e-2)"	"unprognostic (4.71e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.24e-3)"	"unprognostic (8.84e-2)"	"unprognostic (5.83e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.93e-2)"	19.2	17.4	15.8	11.9	17.0	0.6	11.1	7.6	17.6	17.8	24.4	15.3	39.9	9.3	21.9	19.9	16.7	11.8	29.0	18.2	16.7	15.3	5.8	5.9	13.8	3.5	13.7	11.3	24.3	16.7	22.5	10.3	13.5	12.7	26.4	8.0	3.3	14.5	44.9	20.2	8.2	8.0	61.4	13.4	17.3	21.0	18.5	17.2	5.3	6.8	11.4	3.5	35.3	21.9	2.1	0.4	1.0	0.3	0.5	0.4	0.0	20.5	16.5	20.5	18.5	8.0	10.6	26.4	22.9	11.0	13.8	10.5	10.6	7.6	8.7	61.0	35.3	12.4	18.2	23.9	8.6	13.2	0.1	14.8	9.1	14.7	14.2	24.0	1.0	0.3	16.3	10.4	17.9	22.9	11.3	10.9	2.5	0.6	0.4	13.6	4.0	4.1	1.0	34.5	5.4	15.0	6.2	28.9	0.2	6.3	15.9	20.2	16.3	44.9	17.2	15.1	16.3	20.4	1.3	21.2	35.9	26.4	29.8	45.3	1.0	2.5	5.9	19.7	1.1	18.3	1.0	0.3	0.2	0.4	0.1	0.3	0.6	0.4	0.3	0.0	2.1	0.4	0.4	1.0	0.5	0.2	0.4	0.2	0.0	15.8	17.0	7.6	13.7	16.7	15.3	13.7	11.3	12.7	17.2	11.9	31.2	2.2	136.9	114.6	7.8	109.0	56.0	123.1	56.9	21.0	58.9	50.3	3.3	71.8	67.2	59.1	5.1	0.0	86.5	13.1	84.6	122.2	4.7	9.6	9.4	15.9	39.7	22.1	1.8	19.9	53.8	7.0	79.2	5.4	28.6	30.0	72.6	14.4	158.7	10.5	19.1	90.5	115.4	8.0	40.0	117.2	50.6	0.0	23.0	87.2
FBLIM1	"CAL, FBLP-1, migfilin"	ENSG00000162458	"Filamin binding LIM protein 1"	Q8WUP2	1	15756607-15786594	"Predicted intracellular proteins"	"Cell adhesion, Cell shape"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Peritubular cells: 180.0;Sertoli cells: 142.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 54.1;TIME: 84.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA025287, HPA072750"	Approved		Enhanced	"Nucleoli fibrillar center,Cell Junctions,Focal adhesion sites"		NA	NA			"Cell Junctions, Focal adhesion sites"	"Nucleoli fibrillar center"	"HPA025287: AB_1848443, HPA072750: AB_2686554"	"unprognostic (4.10e-2)"	"prognostic unfavorable (4.07e-4)"	"unprognostic (2.26e-1)"	"unprognostic (5.33e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.33e-2)"	"unprognostic (8.77e-3)"	"prognostic unfavorable (6.15e-4)"	"unprognostic (2.02e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (8.64e-4)"	"unprognostic (8.33e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.21e-2)"	11.6	6.0	1.7	12.8	1.4	0.0	10.1	0.8	1.3	21.5	36.6	1.4	26.8	24.6	30.3	15.8	17.8	16.5	60.2	21.7	1.2	1.0	18.2	3.0	14.7	16.1	1.8	1.6	36.0	13.0	13.9	3.8	21.5	2.3	26.7	15.7	9.0	13.0	26.5	4.1	6.2	62.8	18.7	1.3	22.7	18.9	22.3	0.9	1.3	10.3	7.4	6.3	24.7	16.9	1.8	1.3	4.6	1.2	1.6	1.2	0.3	6.5	3.7	3.3	0.1	0.8	1.7	4.5	11.2	17.9	8.3	6.7	1.2	9.9	0.0	24.3	18.0	14.4	12.7	2.4	25.7	4.1	0.0	1.2	0.0	0.9	6.3	21.6	0.0	0.1	8.5	17.2	6.9	16.5	17.2	54.1	0.4	0.2	1.6	2.8	0.1	0.1	0.1	3.4	10.3	4.8	0.0	0.0	0.2	10.4	4.5	0.0	8.0	5.9	0.7	1.3	7.2	1.4	0.1	84.4	11.0	1.5	0.1	5.1	0.1	0.2	0.1	1.6	0.0	0.1	4.6	1.2	1.0	0.7	0.5	0.6	1.0	0.7	0.7	0.4	1.8	1.1	1.2	3.5	1.6	0.7	1.3	0.4	0.3	1.7	1.4	0.8	1.3	1.2	1.0	1.8	1.6	2.3	0.9	11.9	21.5	5.2	54.8	76.6	3.5	30.9	45.9	12.0	29.6	15.7	5.9	5.8	0.0	80.2	2.4	18.4	138.3	0.0	46.9	102.1	26.9	24.2	17.4	1.8	5.3	1.6	44.1	38.1	0.6	1.8	74.2	10.4	13.5	3.6	47.1	10.0	88.8	84.2	180.0	1.2	5.1	142.3	66.2	2.3	1.8	54.8	16.2	6.1	40.4	47.2
FHL2	"DRAL, SLIM3"	ENSG00000115641	"Four and a half LIM domains 2"	Q14192	2	105357712-105438513	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"heart muscle: 312.0;ovary: 80.7"	"Cell type enhanced"	"Detected in many"	9	"Basal glandular cells: 732.1;Extravillous trophoblasts: 503.8;Leydig cells: 525.0;Peritubular cells: 986.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"granulocytes: 7.8;T-cells: 4.6"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 79.9;RPTEC TERT1: 73.7"	"Group enriched"	"Detected in many"	4	"amygdala: 34.7;basal ganglia: 20.4;cerebral cortex: 51.8;hippocampal formation: 36.9;olfactory region: 18.3"	"Low region specificity"	"Detected in many"			"HPA005922, HPA006028, CAB008368"	Enhanced		Enhanced	"Actin filaments,Focal adhesion sites"		NA	Yes			"Actin filaments, Focal adhesion sites"		"CAB008368: AB_591383, HPA005922: AB_1078860, HPA006028: AB_1078858"	"unprognostic (1.04e-1)"	"unprognostic (1.63e-3)"	"unprognostic (3.30e-1)"	"unprognostic (3.42e-2)"	"unprognostic (5.89e-2)"	"prognostic unfavorable (2.01e-4)"	"unprognostic (2.80e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.42e-2)"	"unprognostic (3.34e-2)"	"unprognostic (8.11e-2)"	"prognostic unfavorable (6.42e-5)"	"unprognostic (2.06e-1)"	"unprognostic (3.49e-1)"	"unprognostic (9.92e-3)"	"unprognostic (4.73e-2)"	8.3	9.8	1.5	5.7	3.6	1.5	8.9	0.8	5.6	16.3	10.5	1.4	5.1	6.0	14.8	12.1	9.2	6.8	16.5	312.0	2.5	0.4	5.5	7.8	2.1	2.7	0.9	3.0	80.7	1.6	0.2	4.1	16.7	1.1	12.8	7.4	18.5	6.2	8.7	9.4	5.6	16.9	11.9	0.8	3.9	12.7	13.4	0.7	3.1	6.6	16.9	5.1	18.1	7.6	1.4	1.3	7.8	0.8	1.5	4.6	2.6	22.5	5.3	3.1	0.1	10.1	12.8	29.6	42.8	11.3	27.5	33.1	9.5	35.3	0.0	3.6	52.1	34.0	7.0	4.6	38.9	31.4	0.9	3.5	15.8	6.5	7.1	40.0	0.0	3.5	26.6	21.4	43.2	28.8	55.2	56.0	2.6	4.1	1.3	79.9	0.8	3.6	0.1	6.5	15.8	16.7	0.0	4.8	0.6	73.7	16.0	0.1	1.0	16.0	7.2	11.1	3.2	9.0	0.5	26.9	20.0	20.3	22.1	34.4	0.4	0.0	0.1	31.9	0.0	20.6	7.8	0.8	1.0	2.2	0.4	1.5	1.1	1.8	3.6	0.7	1.4	1.4	2.9	4.5	1.5	0.3	1.3	4.6	2.6	1.5	3.6	0.8	5.6	2.5	0.4	0.9	3.0	1.1	0.7	8.9	6.1	0.0	732.1	416.1	8.9	221.1	15.3	12.0	54.6	27.9	2.0	150.7	3.3	97.9	3.5	21.5	61.9	0.0	105.2	503.8	71.2	120.1	10.3	9.2	22.4	0.0	55.8	20.9	1.2	4.9	525.0	6.6	21.9	4.6	119.3	1.5	144.0	32.8	986.1	15.3	12.4	213.4	132.8	6.6	21.1	259.6	149.4	5.0	30.8	351.4
LIMA1	EPLIN	ENSG00000050405	"LIM domain and actin binding 1"	Q9UHB6	12	50175788-50283546	"Predicted intracellular proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Basal glandular cells: 458.2;Basal keratinocytes: 492.0"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 73.6"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 85.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023871, HPA052645"	Enhanced		Enhanced	"Plasma membrane,Actin filaments,Focal adhesion sites,Cytosol"		NA	NA		160000	"Plasma membrane, Actin filaments"	"Focal adhesion sites, Cytosol"	"HPA023871: AB_1852875, HPA052645: AB_2681898"	"unprognostic (6.22e-2)"	"unprognostic (9.39e-3)"	"unprognostic (8.13e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.08e-2)"	"prognostic unfavorable (1.76e-6)"	"unprognostic (1.63e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.28e-3)"	"unprognostic (6.27e-2)"	"prognostic favorable (2.79e-4)"	"unprognostic (7.12e-2)"	"unprognostic (9.26e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.43e-1)"	50.3	19.8	6.6	22.3	6.8	0.9	34.1	73.6	6.6	30.9	49.2	10.4	21.3	35.2	31.1	22.1	25.0	18.0	31.1	12.6	6.6	5.1	29.3	11.1	23.3	11.8	7.2	4.1	21.1	12.4	12.4	18.6	42.0	15.4	28.2	42.8	20.7	27.0	22.1	10.5	16.3	90.5	33.8	10.4	23.6	30.3	11.8	6.0	12.1	17.0	20.7	18.0	41.8	21.4	0.6	4.4	1.3	2.1	5.8	13.6	2.7	24.5	0.7	7.8	11.5	36.2	36.3	29.7	61.7	43.5	49.7	39.8	9.3	36.2	1.1	5.7	85.0	16.7	28.0	7.0	57.0	43.6	15.6	7.4	10.3	2.8	3.2	23.2	3.6	14.6	24.3	16.8	17.4	50.3	15.0	17.4	4.6	7.1	5.0	16.0	4.2	4.5	1.1	4.0	13.0	3.3	4.5	19.2	0.3	11.5	29.3	5.9	12.6	8.4	17.1	26.4	8.7	8.1	2.2	27.1	21.3	16.4	19.7	10.0	2.7	0.3	4.5	23.2	4.1	9.1	0.1	0.2	1.3	6.4	1.0	2.5	0.1	8.1	7.8	4.4	0.6	3.3	5.9	0.1	5.8	2.1	1.1	13.6	2.7	6.6	6.8	73.6	5.6	6.6	5.1	7.2	4.1	15.4	6.0	41.7	69.6	5.7	458.2	492.0	15.2	4.8	91.7	64.3	190.0	113.4	151.2	92.0	13.3	118.0	57.4	79.0	270.8	0.0	268.0	306.1	86.4	160.9	24.3	17.8	31.1	6.4	118.0	121.5	12.4	9.6	69.9	18.4	86.0	15.4	122.6	21.8	175.8	221.0	72.9	21.7	85.9	64.7	111.9	28.1	7.0	254.8	53.5	31.6	178.0	293.9
LPP		ENSG00000145012	"LIM domain containing preferred translocation partner in lipoma"	Q93052	3	188153284-188890671	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 127.8;urinary bladder: 105.1"	"Cell type enhanced"	"Detected in all"	11	"Early spermatids: 514.4;Late spermatids: 1329.9;Smooth muscle cells: 529.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 18.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 29.5;EFO-21: 36.6;U-698: 61.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA011133, HPA017342"	Enhanced		Enhanced	"Focal adhesion sites,Cytosol"		NA	NA		520000	"Focal adhesion sites, Cytosol"		"HPA011133: AB_1853247, HPA017342: AB_1853249"	"unprognostic (1.50e-1)"	"unprognostic (4.97e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.05e-1)"	"unprognostic (2.43e-3)"	"unprognostic (7.97e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.56e-2)"	"unprognostic (3.44e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.57e-3)"	"unprognostic (2.25e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.48e-1)"	19.6	4.2	2.7	29.5	2.8	3.1	12.5	3.0	2.7	42.2	29.9	2.1	19.6	5.0	68.6	14.9	59.7	10.0	37.9	9.3	2.6	2.8	10.9	5.3	11.4	6.0	2.8	1.6	26.1	4.4	4.7	3.2	5.2	3.0	37.7	12.8	8.5	7.0	28.4	11.6	5.9	17.2	127.8	3.2	9.5	12.1	30.7	1.5	5.1	5.4	4.2	7.8	105.1	38.3	5.9	4.9	18.0	4.5	4.3	5.0	1.4	7.7	7.1	5.2	3.5	11.3	11.7	5.6	5.1	6.5	3.7	2.5	12.9	3.7	29.5	36.6	11.4	4.6	3.3	1.5	3.4	9.4	3.2	1.7	1.4	5.5	3.4	4.8	0.6	1.7	8.3	4.8	8.3	7.2	5.4	6.2	1.6	0.0	0.6	6.5	2.4	1.5	0.6	2.1	4.9	2.3	1.9	3.9	0.1	4.1	8.2	0.3	0.0	10.9	3.6	6.1	9.0	2.8	2.4	13.4	8.6	6.6	6.1	12.5	0.0	1.1	61.0	4.3	1.3	7.7	0.8	4.5	1.9	5.0	4.2	3.2	2.9	4.3	3.6	2.4	5.9	2.3	2.9	18.0	4.3	4.0	4.9	1.6	1.4	2.7	2.8	3.0	2.7	2.6	2.8	2.8	1.6	3.0	1.5	83.4	55.0	41.3	72.1	69.3	7.7	101.6	99.3	40.2	83.0	66.3	13.7	35.7	24.9	114.3	514.4	83.0	142.7	23.3	78.6	20.6	102.9	124.2	17.4	84.7	36.8	4.8	74.4	114.2	61.5	1329.9	208.5	76.2	75.9	36.1	86.3	27.1	104.6	158.4	448.3	61.0	7.4	329.8	529.6	8.1	6.6	59.6	15.6	39.5	123.5	109.3
MISP	"C19orf21, Caprice, DKFZp686H18209, MISP1"	ENSG00000099812	"Mitotic spindle positioning"	Q8IVT2	19	751126-764318	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"gallbladder: 24.6;intestine: 63.8"	"Group enriched"	"Detected in many"	5	"Enterocytes: 892.4;Paneth cells: 434.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 133.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 37.2;HaCaT: 27.6;hTCEpi: 25.9;MCF7: 19.0;OE19: 23.2;SK-BR-3: 42.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA049511, HPA062232"	Enhanced		Enhanced	"Plasma membrane,Focal adhesion sites"		No	No			"Plasma membrane, Focal adhesion sites"		"HPA049511: AB_2680798, HPA062232: AB_2684719"	"unprognostic (7.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.64e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.56e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.19e-3)"	"unprognostic (6.78e-3)"	"unprognostic (2.29e-1)"	"unprognostic (4.80e-1)"	"unprognostic (5.27e-2)"	0.5	0.1	0.3	7.9	0.3	0.0	0.7	0.2	0.2	1.5	42.8	0.2	0.2	45.9	0.7	0.8	0.4	2.4	24.6	0.2	0.5	0.2	6.9	0.4	6.8	0.2	0.3	0.3	2.2	2.0	0.0	4.2	2.1	0.2	2.2	13.0	0.2	0.5	0.5	0.2	0.3	63.8	0.7	0.2	0.2	5.8	0.2	0.2	0.3	0.2	0.8	0.2	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	37.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	12.8	13.7	3.2	3.6	0.0	0.0	27.6	0.0	11.6	0.0	0.0	0.0	0.0	14.6	3.9	0.0	0.0	0.5	0.0	25.9	0.1	1.4	0.0	0.0	0.0	0.0	0.1	0.0	19.0	0.0	0.2	0.0	23.2	7.6	0.0	0.1	0.3	9.3	10.3	0.4	0.1	13.2	42.0	0.0	0.0	9.1	0.0	0.0	0.0	4.7	0.5	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.2	0.5	0.2	0.3	0.3	0.2	0.2	35.7	10.1	2.2	4.0	0.1	0.0	0.4	2.5	26.8	15.9	10.4	0.0	0.3	1.7	48.8	0.4	0.0	892.4	0.0	41.8	2.6	0.3	34.5	9.2	0.0	0.1	0.0	55.7	0.0	0.0	0.7	0.0	0.8	0.0	1.0	139.5	0.0	94.0	434.9	0.0	21.7	0.0	0.0	0.0	0.0	1.5	0.3	1.7	0.0	93.0	40.9
PDLIM7	ENIGMA	ENSG00000196923	"PDZ and LIM domain 7"	Q9NR12	5	177483394-177497606	"Predicted intracellular proteins"	"Differentiation, Osteogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 159.6"	"Cell type enhanced"	"Detected in many"	6	"Ductal cells: 173.8;Exocrine glandular cells: 213.2;Pancreatic endocrine cells: 210.7;Peritubular cells: 209.7;Sertoli cells: 161.7;Smooth muscle cells: 171.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 27.2;eosinophil: 20.5;neutrophil: 80.6"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 80.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018794, HPA048815"	Approved		Enhanced	"Actin filaments,Focal adhesion sites"		NA	NA		7600000	"Actin filaments, Focal adhesion sites"		"HPA018794: AB_1855155, HPA048815: AB_2680530"	"unprognostic (7.70e-3)"	"unprognostic (3.75e-2)"	"unprognostic (9.27e-3)"	"prognostic unfavorable (5.45e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.48e-2)"	"unprognostic (9.18e-3)"	"prognostic unfavorable (4.07e-4)"	"unprognostic (5.01e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (6.19e-10)"	"unprognostic (6.72e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.68e-2)"	12.4	5.6	3.7	21.1	9.3	12.5	8.3	0.5	5.9	54.6	76.0	3.2	42.6	9.0	85.0	35.8	33.9	35.5	52.3	11.1	3.8	5.0	8.3	2.4	11.6	8.9	3.5	5.8	28.2	3.1	2.1	10.3	11.5	5.6	42.0	7.6	17.6	9.1	61.7	159.6	5.3	16.5	129.5	3.1	12.7	27.0	11.7	2.4	3.7	5.4	24.9	6.5	67.8	19.6	1.8	4.8	80.6	8.4	0.4	1.4	3.9	24.9	5.0	23.9	18.8	6.5	11.9	24.2	47.9	26.1	27.3	19.6	9.6	22.6	4.5	49.5	29.3	15.0	12.1	3.9	32.4	6.3	6.2	5.8	14.7	16.3	9.0	17.7	7.8	49.6	25.8	5.5	21.8	10.5	38.7	16.3	4.1	10.9	3.2	19.7	19.3	1.4	17.3	16.5	4.8	21.5	29.1	21.3	2.8	18.2	5.1	3.7	7.8	18.7	3.6	9.1	8.4	5.1	7.0	58.6	32.9	35.7	12.5	43.7	0.8	0.9	5.3	15.6	8.4	7.4	27.2	8.4	20.5	0.9	3.9	1.1	1.8	0.6	1.4	4.8	1.0	0.6	0.7	80.6	0.4	4.9	0.3	1.2	3.9	3.7	9.3	0.5	5.9	3.8	5.0	3.5	5.8	5.6	2.4	0.0	1.1	5.9	34.1	12.9	5.2	16.1	5.1	4.0	2.3	24.4	13.7	10.1	21.6	173.8	19.2	30.0	1.3	0.0	213.2	44.5	47.3	13.0	17.3	0.9	64.5	7.9	3.4	50.3	15.5	30.6	41.4	23.5	10.1	34.3	1.9	12.4	210.7	35.1	209.7	6.7	20.4	161.7	171.6	10.9	35.2	13.8	11.8	14.9	1.7	21.1
PXN		ENSG00000089159	Paxillin	P49023	12	120210439-120265771	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Extravillous trophoblasts: 124.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 49.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003841, HPA051309"	Supported		Enhanced	"Focal adhesion sites,Centrosome,Cytosol"		NA	NA			"Focal adhesion sites"	"Centrosome, Cytosol"	"CAB003841: AB_562188, HPA051309: AB_2681436"	"unprognostic (4.00e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.55e-3)"	"prognostic unfavorable (1.09e-4)"	"prognostic unfavorable (3.72e-5)"	"prognostic unfavorable (7.12e-5)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (3.12e-2)"	"unprognostic (9.19e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.75e-2)"	35.4	26.2	17.9	26.7	16.5	31.6	45.9	15.5	18.6	25.0	29.0	12.4	31.7	25.6	27.6	30.9	16.0	29.8	31.8	26.2	18.0	7.6	27.6	13.1	35.8	42.9	15.7	8.1	14.8	16.3	17.6	13.9	34.0	15.8	24.9	23.5	24.7	22.1	40.1	98.5	19.7	34.7	44.4	20.3	34.0	20.6	19.8	14.4	9.9	26.7	22.8	11.6	30.1	45.7	0.5	7.6	49.5	12.3	14.4	26.3	14.5	33.2	16.5	5.9	5.9	11.9	31.0	40.1	28.2	24.6	23.0	12.1	19.2	21.0	2.3	18.5	28.6	22.3	23.8	4.1	51.4	18.4	1.8	3.7	0.4	12.2	6.9	17.2	0.5	0.7	15.1	33.6	24.0	27.4	26.0	40.8	6.2	5.9	3.8	44.9	22.1	2.0	0.7	8.4	14.5	57.5	4.9	9.8	2.0	23.6	32.0	9.7	2.9	25.3	7.8	15.2	14.5	19.2	2.7	53.7	16.0	17.5	19.9	33.5	4.0	2.2	0.8	46.0	5.0	31.2	9.8	12.3	13.4	26.3	4.4	14.2	0.5	12.1	17.2	7.6	0.4	9.6	12.8	49.5	14.4	0.2	1.2	9.1	14.5	17.9	16.5	15.5	18.6	18.0	7.6	15.7	8.1	15.8	14.4	53.6	30.4	3.0	29.8	37.5	7.1	11.5	25.5	28.1	35.2	40.1	31.4	31.3	16.6	30.3	1.2	56.8	59.3	0.0	34.6	124.5	18.0	29.6	17.4	15.3	29.4	11.1	52.5	57.1	49.0	1.6	22.5	13.7	25.3	10.0	49.9	6.9	56.8	50.3	17.7	11.6	30.4	6.5	10.5	3.8	8.0	16.9	20.9	28.7	28.4	33.9
TES	"DKFZP586B2022, TESS-2, TESTIN"	ENSG00000135269	"Testin LIM domain protein"	Q9UGI8	7	116210493-116258783	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 226.3;Early spermatids: 327.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 51.4;hTCEpi: 58.1;SK-BR-3: 58.3"					"Low region specificity"	"Detected in single"			"HPA015269, HPA018123"	Approved		Supported	"Plasma membrane,Cell Junctions,Focal adhesion sites,Cytosol"		NA	NA			"Focal adhesion sites, Cytosol"	"Plasma membrane, Cell Junctions"	"HPA015269: AB_1857899, HPA018123: AB_1857900"	"unprognostic (9.81e-2)"	"unprognostic (5.53e-3)"	"unprognostic (4.79e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.01e-1)"	"unprognostic (6.08e-3)"	"unprognostic (1.84e-3)"	"unprognostic (4.81e-3)"	"unprognostic (8.81e-3)"	"unprognostic (6.19e-3)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (1.60e-2)"	"prognostic favorable (8.71e-5)"	"unprognostic (1.50e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.86e-1)"	12.1	2.9	1.2	36.4	1.5	8.6	22.1	0.8	1.2	42.4	53.1	1.5	43.9	9.3	47.6	21.2	22.6	19.5	15.3	7.9	1.6	1.4	14.3	4.6	16.8	20.3	1.9	0.7	17.1	12.3	3.1	4.2	21.2	3.3	26.1	16.8	5.0	19.0	50.9	5.2	9.1	27.4	84.5	3.0	19.1	25.2	18.4	0.7	17.1	26.3	11.2	18.4	71.6	33.9	26.8	21.9	56.8	39.6	49.0	40.5	34.7	24.4	5.2	5.9	0.0	2.6	6.7	13.8	12.8	6.2	2.4	2.3	12.9	27.3	0.0	51.4	8.9	0.3	25.2	3.1	18.8	5.9	12.1	10.1	2.4	12.1	6.3	15.7	11.1	0.0	14.9	58.1	8.3	21.1	16.6	6.7	0.0	2.5	8.6	0.6	5.0	0.0	0.1	3.9	28.4	14.9	0.0	0.0	9.6	24.2	9.4	2.7	25.5	18.7	58.3	14.1	17.9	0.0	4.5	11.3	0.1	0.3	18.9	0.1	20.5	9.9	0.2	1.6	5.7	19.4	56.8	20.2	53.4	40.5	32.6	39.0	26.8	31.0	36.6	21.9	23.8	31.0	35.0	10.5	49.0	39.6	5.4	31.5	34.7	1.2	1.5	0.8	1.2	1.6	1.4	1.9	0.7	3.3	0.7	226.3	36.4	52.3	147.2	177.9	2.3	14.5	38.2	84.3	97.8	34.9	11.8	16.7	18.3	104.8	327.4	24.0	101.5	0.0	97.9	69.1	27.0	83.0	17.4	9.9	14.9	1.6	48.4	15.4	52.9	82.2	1.7	62.3	27.0	36.1	57.8	23.0	142.2	58.6	0.4	10.3	12.6	6.5	20.6	18.2	9.7	107.3	24.4	57.4	44.4	125.3
TNS1	"DKFZp586K0617, MXRA6, PPP1R155, TNS"	ENSG00000079308	"Tensin 1"	Q9HBL0	2	217799588-218010421	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 153.0"	"Cell type enhanced"	"Detected in many"	10	"Cardiomyocytes: 299.8;Peritubular cells: 473.8;Sertoli cells: 362.2;Smooth muscle cells: 208.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 46.9;ASC TERT1: 25.6;fHDF/TERT166: 22.2;REH: 24.4;TIME: 21.7"	"Low region specificity"	"Detected in all"							"CAB018774, HPA036089, HPA036090"	Approved		Enhanced	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"CAB018774: AB_2207032, HPA036089: AB_10796111, HPA036090: AB_10794322"	"unprognostic (4.63e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (4.13e-2)"	"unprognostic (5.46e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.20e-3)"	"unprognostic (7.34e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.28e-3)"	"unprognostic (5.57e-2)"	"unprognostic (9.74e-2)"	"unprognostic (4.71e-3)"	"unprognostic (5.60e-3)"	"unprognostic (2.88e-2)"	"unprognostic (7.49e-2)"	"prognostic unfavorable (5.19e-4)"	77.6	15.6	5.2	21.1	13.7	9.2	33.5	2.9	8.9	50.0	68.9	17.2	45.6	6.0	61.1	29.8	52.0	31.1	46.7	41.0	6.8	4.8	24.0	9.2	28.9	6.1	15.8	4.1	32.3	14.1	6.0	3.8	14.0	14.3	55.1	11.4	27.6	12.8	63.4	40.8	10.1	17.2	153.0	13.7	17.0	30.0	22.6	12.2	1.5	18.3	9.8	4.0	124.6	53.6	0.2	1.0	0.9	1.7	0.0	0.0	2.9	0.0	0.1	3.0	0.0	46.9	25.6	0.3	7.9	2.6	0.4	0.3	3.4	0.0	0.0	4.6	22.2	0.5	0.5	0.3	0.4	0.2	3.1	0.2	6.7	2.0	0.9	3.5	0.0	0.8	12.1	0.0	8.5	0.0	15.3	11.1	0.0	0.2	0.8	6.6	0.9	0.0	0.4	0.3	0.0	0.1	24.4	5.9	0.3	1.6	0.0	0.7	3.5	1.3	3.4	0.8	2.2	1.1	2.4	21.7	5.7	10.4	5.8	1.7	0.4	0.0	0.0	3.3	0.9	0.4	0.0	0.4	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.9	0.0	0.7	1.0	0.0	2.9	5.2	13.7	2.9	8.9	6.8	4.8	15.8	4.1	14.3	12.2	160.8	81.8	4.6	45.8	14.3	2.7	299.8	33.1	20.1	36.4	14.0	0.0	8.0	6.6	34.4	1.7	55.0	0.0	116.8	16.8	1.1	42.2	8.9	29.0	28.8	13.3	39.7	0.0	74.3	14.9	4.3	157.1	14.6	10.1	0.0	0.0	12.6	16.8	0.0	473.8	20.9	1.4	362.2	208.1	0.7	2.0	10.3	1.6	5.3	0.0	14.9
TNS3	"FLJ13732, H_NH0549I23.2, TEM6, TENS1"	ENSG00000136205	"Tensin 3"	Q68CZ2	7	47275154-47582558	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 66.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 5.8;intermediate monocyte: 4.7;memory B-cell: 3.7;myeloid DC: 4.0;naive B-cell: 2.9;non-classical monocyte: 4.4;plasmacytoid DC: 5.6"	"Group enriched"	"Detected in many"	6	"B-cells: 3.7;dendritic cells: 5.6;monocytes: 5.8"	"Cell line enhanced"	"Detected in many"		"A549: 65.8;LHCN-M2: 42.4"	"Low region specificity"	"Detected in all"							"HPA055338, HPA056015"	Approved		Enhanced	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"HPA055338: AB_2682789, HPA056015: AB_2683010"	"unprognostic (1.46e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.02e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.05e-1)"	"unprognostic (8.00e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.70e-1)"	"unprognostic (6.60e-2)"	"prognostic favorable (5.21e-4)"	"unprognostic (3.13e-2)"	"unprognostic (4.41e-2)"	"unprognostic (3.20e-2)"	"unprognostic (9.09e-3)"	46.9	18.5	16.4	19.3	12.7	2.8	29.8	8.1	11.7	18.2	15.7	11.4	9.1	9.9	27.4	13.9	7.7	12.3	29.6	13.5	12.1	13.2	27.3	24.9	25.1	37.7	16.0	3.6	22.4	35.5	16.4	5.5	44.9	9.6	15.0	9.3	40.3	36.4	11.7	14.9	6.7	20.7	14.7	11.6	42.7	13.9	9.6	7.8	3.8	23.8	9.6	19.9	12.5	19.3	3.7	5.6	0.8	5.8	0.1	0.2	1.8	6.3	65.8	4.0	6.9	9.2	7.5	12.8	5.8	33.4	5.7	8.8	14.7	8.6	3.2	10.4	21.2	21.5	12.2	6.4	9.5	5.2	0.0	0.4	9.0	9.5	7.8	9.5	0.0	0.1	7.4	4.1	3.3	5.2	37.5	4.5	0.0	0.0	20.3	42.4	3.9	0.0	0.2	3.8	9.2	7.9	2.9	9.8	10.7	19.8	13.1	0.4	8.2	11.5	2.3	6.4	21.1	8.8	6.7	17.9	8.9	7.1	0.1	8.9	13.1	16.9	7.6	2.2	6.3	32.2	0.2	5.8	0.0	0.1	4.7	0.2	3.7	0.0	0.0	4.0	2.9	0.0	0.0	0.8	0.1	4.4	5.6	0.0	1.8	16.4	12.7	8.1	11.7	12.1	13.2	16.0	3.6	9.6	7.8	62.5	12.0	3.7	7.3	4.2	1.4	17.3	33.1	16.0	25.0	29.6	0.0	21.4	1.7	14.4	9.5	6.9	28.0	0.0	15.8	47.3	17.5	2.8	0.0	35.1	66.7	0.0	14.5	40.5	35.8	11.8	5.8	13.7	15.1	11.8	15.6	34.2	21.0	8.6	14.5	11.5	1.4	25.8	8.2	1.7	3.4	2.9	25.1	1.9	15.3	2.1
VCL		ENSG00000035403	Vinculin	P18206	10	73995193-74121363	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	Actin-binding	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 304.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 90.2;hTERT-RPE1: 88.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002131, CAB002453, HPA063777"	Enhanced		Enhanced	"Focal adhesion sites"		NA	NA		1800000000	"Focal adhesion sites"		"CAB002453: AB_564057, HPA002131: AB_1080570, HPA063777: AB_2685121"	"unprognostic (8.49e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.14e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.34e-1)"	"unprognostic (9.62e-3)"	"unprognostic (2.72e-3)"	"unprognostic (2.67e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (2.75e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.68e-2)"	"unprognostic (4.03e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.37e-3)"	31.9	7.3	4.3	19.0	6.0	8.6	24.4	5.4	5.3	37.9	41.2	6.7	24.4	8.0	72.1	29.2	36.1	27.6	44.8	35.0	4.7	3.9	20.8	6.9	25.9	9.3	3.8	5.5	29.2	12.8	18.1	7.6	22.6	9.6	43.3	18.0	20.2	14.9	38.8	59.1	14.4	20.2	113.1	3.8	23.6	23.6	29.5	3.3	3.0	15.3	20.5	11.7	73.9	26.1	3.7	12.9	21.6	11.3	2.8	9.9	15.6	22.4	15.4	27.9	19.7	35.0	40.8	15.4	29.7	90.2	20.3	23.1	13.8	19.6	1.0	24.8	51.8	13.9	28.9	18.3	14.9	21.5	1.9	7.8	10.7	15.0	5.7	19.2	2.1	16.4	33.7	4.0	27.5	25.1	88.6	27.1	1.8	7.7	2.2	33.8	3.8	0.3	2.5	13.2	10.8	54.5	3.7	14.6	2.8	29.1	29.1	1.0	4.1	16.5	18.7	8.5	25.7	8.6	3.2	36.2	22.2	9.3	10.7	27.7	0.4	0.9	4.4	25.9	6.0	6.2	8.5	7.6	21.6	9.9	10.8	7.0	3.7	4.7	5.1	12.9	1.6	1.8	3.6	7.0	2.8	11.3	5.0	1.2	15.6	4.3	6.0	5.4	5.3	4.7	3.9	3.8	5.5	9.6	3.3	92.3	37.8	11.5	94.3	102.0	13.5	304.7	50.9	28.1	77.3	40.1	80.5	44.5	3.3	59.0	2.3	54.3	61.0	0.0	53.1	67.5	69.7	88.5	33.6	30.6	21.4	15.9	36.8	73.1	36.2	4.7	46.3	28.0	25.3	9.0	29.5	12.2	85.6	31.9	72.2	12.4	35.2	103.5	102.7	14.2	10.9	81.3	33.2	19.8	37.5	76.0
